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Zinc oxide nanocrystals (ZnO NCs), thanks to their unique properties, are 
receiving much attention for their use in nanomedicine, in particular for therapy 
against cancer [1]. To be efficiently employed as diagnostic and therapeutic (yet 
theranostic) tools [2], highly dispersed, stable and non-toxic nanoparticles are 
required. In the case of ZnO NCs, there is still a lack of knowledge about 
cytotoxicity mechanisms and stability in the biological context, as well as 
immunological response and haemocompatible features.  
Most of these above-mentioned behaviours strongly depends on physico-
chemical and surface properties of the nanoparticles. We thus propose a novel 
approach to stabilize the ZnO NCs in various biological media, focusing on NC 
aggregation and biodegradation as a function of the surface functionalization.  
We synthesized bare ZnO NCs, amino-propyl functionalized ones, and lipid 
bilayer-shielded NCs, and we characterized their morphological, chemical and 
physical properties. The stability behavior of the three different samples was 
evaluated, comparing their biodegradation profiles in different media, i.e. organic 
solvents, water, and different simulated and biological fluids. The studies aim to 
investigate how the particle surface functionalizations, and thus chemistry and 
charge, could influence their hydrodynamic size, zeta potential and consequent 
aggregation and degradation in the different solvents. We demonstrated that 
bare and amino-functionalized ZnO NCs strongly and rapidly aggregate when 
suspended in both simulated and biological media. Long-term biodegradation 
analysis showed small dissolution into potentially cytotoxic Zn-cations, also 
slightly affecting their crystalline structure. In contrast, high colloidal stability 
and integrity was retained for lipid-shielded ZnO NCs in all media, rendering 
them the ideal candidates for further theranostic applications [3].  
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